Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Utilization of next generation sequencing (NGS) in stage IV gastrointestinal (GI) cancer patients (pts) and efficacy of electronic reminder notification (ERN) in improving utilization of NGS in the private practice community-based setting.
Authors
Kapil Foster
Astera Cancer Care, East Brunswick, NJ
Kapil Foster , Carina Cedeno , Stephanie Marks , Percy Yeung , Ellen A. Ronnen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Quality of Care/Quality Improvement
DOI
10.1200/JCO.2022.40.4_suppl.073
Abstract #
73
Poster Bd #
D5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical outcomes and molecular characteristics of patients with pancreatic acinar cell carcinoma.
First Author: Cody Eslinger
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of neoadjuvant preoperative short-course radiation followed by envafolimab plus CAPEOX in microsatellite stable (MSS)/mismatch repair proficient (pMMR) locally advanced rectal cancer.
First Author: Sheng Dai
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Sonoporation for disrupting the pancreatic cancer microenvironment to enhance chemotherapy delivery and improve outcomes.
First Author: James Posey
Poster
2022 ASCO Annual Meeting
Trial in progress: Phase I study of SY-5609, a potent, selective CDK7 inhibitor, with initial expansion in adults with metastatic pancreatic cancer.
First Author: Manish Sharma